Why is Acasti and their China partner wasting money creating a slightly modified version of Lozaza? Insurers will never cover it in the US, they'll force patients to use GL instead, unless CaPre lowers TGs by a large % better than L/GL, and even if it does I can still see insurers saying "step therapy, must fail on GL first", especially since GL is very cheap now. Also, CaPre is 4 g in a single capsule?!? How on earth are you supposed to swallow a horse pill like that?!? AMRN came out with the 500 mg version of V because some people have trouble swallowing the 1 g capsule - and I can verify it's the largest pill/capsule amongst all the DS and Rx drugs I take, but it's shape and gel coating make it relatively easy to swallow for me, but I cannot imagine being able to take a capsule 4x the size w/o gagging or choking. Obviously the patients in their small P2 trial managed to do it somehow, but I seriously wonder how many people are going to be able to do it, especially if they have a strong gag reflex like me.